Scholars Central

Short communicationPublished 26 Jul 2016

ALLHAT: implications in the diabetic population

Authors: Samy I McFarlane

Clinical Practice

Volume 1 · Issue 1 · Pages 43

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) is the largest hypertension study ever conducted. It included a large number of diabetic patients, representing nearly a third of its entire cohort of 42,448 participants. Furthermore, the study showed a significant increase in the number of incident diabetes cases with the use of chlorothalidone throughout the trial. In this report we discuss the major ALLHAT results with emphasis on the diabetic population, a particularly high-risk group for cardiovascular events, the primary outcome for the trial.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Clinical Practice.

All its articles

Article · 28 Mar 2025

Using

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Practice
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Samy I McFarlane”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels